115 related articles for article (PubMed ID: 25874012)
1. Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients.
Luo FY; Liu ZH; Hu QH; Lin GQ; Tang CE; Zhang WX; Zhuang W
J Cancer; 2015; 6(5):477-81. PubMed ID: 25874012
[TBL] [Abstract][Full Text] [Related]
2. BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.
Tao YM; Huang JL; Zeng S; Zhang S; Fan XG; Wang ZM; Yang HX; Yuan XH; Wang P; Wu F; Luo J; Zeng DY; Shen H
Hepatology; 2013 Jun; 57(6):2326-37. PubMed ID: 23325674
[TBL] [Abstract][Full Text] [Related]
3. Expression of BTBD7 in primary salivary adenoid cystic carcinoma and correlation with Slug and prognosis.
Yang L; Wang T; Zhang J; Liu Z; Wang X
Cancer Biomark; 2016 Jun; 17(2):179-85. PubMed ID: 27540976
[TBL] [Abstract][Full Text] [Related]
4. High BTBD7 expression positive is correlated with SLUG-predicted poor prognosis in hormone receptor-negative breast cancer.
Li ZX; Huang ZN; Luo H; Yang XB; Wang YL; Chen JX; Ma XK; Xu F; Wang TT; Lin L
Ann Transl Med; 2021 Aug; 9(15):1252. PubMed ID: 34532389
[TBL] [Abstract][Full Text] [Related]
5. BTBD7 silencing inhibited epithelial- mesenchymal transition (EMT) via regulating Slug expression in human salivary adenoid cystic carcinoma.
Yang L; Wang T; Zhang J; Wang X
Cancer Biomark; 2017 Dec; 20(4):461-468. PubMed ID: 28946551
[TBL] [Abstract][Full Text] [Related]
6. BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer.
Shu J; Wang L; Han F; Chen Y; Wang S; Luo F
Biomed Res Int; 2019; 2019():5937635. PubMed ID: 31886230
[TBL] [Abstract][Full Text] [Related]
7. The Role of BTBD7 in Normal Development and Tumor Progression.
Liu Y; Song J; Gu J; Xu S; Wang X; Liu Y
Technol Cancer Res Treat; 2023; 22():15330338231167732. PubMed ID: 37050886
[TBL] [Abstract][Full Text] [Related]
8. BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer.
Chen J; Lai YH; Ooi S; Song Y; Li L; Liu TY
Breast Cancer Res Treat; 2020 Nov; 184(2):287-300. PubMed ID: 32772271
[TBL] [Abstract][Full Text] [Related]
9. Effects of Btbd7 knockdown on the proliferation of human dental pulp cells and expression of Dspp.
Bao Q; Zhang J; Wang XX
Int J Clin Exp Pathol; 2018; 11(3):1460-1465. PubMed ID: 31938244
[No Abstract] [Full Text] [Related]
10. BTB/POZ domain-containing protein 7 is inversely associated with fibronectin expression in salivary adenoid cystic carcinoma.
Liu Y; Song J; Zhang J; Yang L; Liu Z; Wang X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):468-477. PubMed ID: 29366608
[TBL] [Abstract][Full Text] [Related]
11. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway].
Hu K; Wang Z; Tao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec; 39(12):1221-7. PubMed ID: 25544168
[TBL] [Abstract][Full Text] [Related]
12. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
[TBL] [Abstract][Full Text] [Related]
14. Sleeping beauty genetic screen identifies miR-23b::BTBD7 gene interaction as crucial for colorectal cancer metastasis.
Grisard E; Coan M; Cesaratto L; Rigo I; Zandonà L; Paulitti A; Andreuzzi E; Rampioni Vinciguerra GL; Poletto E; Del Ben F; Brisotto G; Biscontin E; Turetta M; Dassi E; Mirnezami A; Canzonieri V; Vecchione A; Baldassarre G; Mongiat M; Spizzo R; Nicoloso MS
EBioMedicine; 2019 Aug; 46():79-93. PubMed ID: 31303496
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
16. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
17. Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer.
Zhou Y; Liao Q; Han Y; Chen J; Liu Z; Ling H; Zhang J; Yang W; Oyang L; Xia L; Wang L; Wang H; Xue L; Wang H; Hu B
J Cancer; 2016; 7(14):2100-2109. PubMed ID: 27877226
[No Abstract] [Full Text] [Related]
18. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
20. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.
Hsu CY; Lin CH; Jan YH; Su CY; Yao YC; Cheng HC; Hsu TI; Wang PS; Su WP; Yang CJ; Huang MS; Calkins MJ; Hsiao M; Lu PJ
Am J Respir Crit Care Med; 2016 Apr; 193(8):869-80. PubMed ID: 26595459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
